Obesity and gender influence cortisol secretion and metabolism in man

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 5, 1998, Pages 1806-1809

  Andrew, Ruth ^a   Phillips, David I W ^b   Walker, Brian R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; HYDROCORTISONE; OXIDOREDUCTASE; STEROID 5ALPHA REDUCTASE;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; FEMALE; GAS CHROMATOGRAPHY; GENDER; HORMONAL REGULATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYDROCORTISONE URINE LEVEL; LIVER METABOLISM; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE; STEROID METABOLISM;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; CHOLESTENONE 5 ALPHA-REDUCTASE; CORTISONE; ESTROGEN REPLACEMENT THERAPY; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASES; MALE; MIDDLE AGED; OBESITY; OXIDOREDUCTASES; SEX CHARACTERISTICS;

EID: 0031784958     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.5.1806     Document Type: Article

References (23)

1. Marin P, Darin M, Amemiya T, Andersson B, Jern S, Bjorntorp P. 1992 Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism. 41:882-886.
2. Ljung T, Andersson B, Bengtsson B, Bjorntorp P, Marin P. 1996 Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study. Obesity Research. 4:277-282.
3. Hautanen A, Adlercreutz H. 1993 Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome. J Intern Med. 234:461-469.
4. Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R, Labate AMM, Barabara L. 1993 The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab. 77:341-346.
5. Phillipou G, Palermo M, Shackleton CHL. 1996 Apparent cortisone reductase deficiency; a unique form of hypercortisolism. J Clin Endocrinol Metab. 81:3855-3860.
6. Walker BR, Campbell JC, Fraser R, Stewart PM, Edwards CRW. 1992 Mineralocorticoid excess and inhibition of 11β-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol (Oxf). 27:483-492.
7. Jamieson PM, Chapman KE, Edwards CRW, Seckl JR. 1995 11β-Hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology. 136:4754-4761.
8. Bujalska IJ, Kumar S, Stewart PM. 1997 Does central obesity reflect 'Cushing's disease of the omentum'? Lancet. 349:1210-1213.
9. Low SC, Chapman KE, Edwards CRW, Wells T, Robinson ICAF, Seckl JR. 1994 Sexual dimorphism of hepatic 11β-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patterns. J Endocrinol. 143:541-548.
10. Raven PW, Taylor NF. 1996 Sex differences in the human metabolism of cortisol. Endocrine Research. 22:751-755.
11. Lax ER, Rumstadt F, Plasczyk H. 1983 Antagonistic action of estrogens, flutamide, and human growth hormone on androgen-induced changes in the activities of some enzymes of hepatic steroid metabolism in the rat. Endocrinology. 113:1043-1055.
12. Mode A, Norstedt G. 1982 Effects of gonadal steroid hormones on the hypothalmo-pituitary-liver axis in the control of sex differences in hepatic steroid metabolism in the rat. J Endocrinol. 95:181-187.
13. Phillips DIW, Barker DJP, Hales CN, Hirst S, Osmond C. 1994 Thinness at birth and insulin resistance in adult life. Diabetologia. 37:150-154.
14. Best R, Nelson SM, Walker BR. 1997 Dexamethasone and 11-dehydrodexamethasone as tools to investigate the isozymes of 11β-hydroxysteroid dehydrogenase in vitro and in vivo. J Endocrinol. 153:41-48.
15. Best R, Walker BR. 1997 Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11β-hydroxysteroid dehydrogenase in vivo. Clin Endocrinol (Oxf). 47:231-236.
16. Zumoff B, Fukushima DK, Hellman L. 1974 Intercomparison of four methods for measuring cortisol production. J Clin Endocrinol Metab. 38:169-175.
17. Ulick S, Tedde R, Wang JZ. 1992 Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab. 74:593-599.
18. Palermo M, Shackleton CHL, Mantero F, Stewart PM. 1996 Urinary free cortisone and the assessment of 11beta-hydroxysteroid dehydrogenase activity in man. Clinical Endocrinology. 45:605-611.
19. Weaver JU, Kelly WF, Monson JP, Taylor NF, Wood PJ. 1997 11β-HSD-1 and 11β-HSD-2 activity in hypopituitary adults; effect of body fat distribution and insulin sensitivity on serum and urine cortisol/cortisone ratio and 11oxo/11OH ratio. J Endocrinol. 152:P276 (Abstract).
20. Kotelevtsev YV, Holmes MC, Burchell A, Houston PM, Scholl D, Jamieson PM, Best R, Brown RW, Edwards CRW, Seckl JR, Mullins JJ. 1997 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid inducible responses and resist hyperglycaemia on obesity and stress. Proc Natnl Acad Sci USA. 94:14924-14929.
21. Walker BR, Connacher AA, Lindsay RM, Webb DJ, Edwards CRW. 1995 Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J Clin Endocrinol Metab. 80:3155-3159.
22. Soro A, Ingram MC, Tonolo G, Glorioso N, Fraser R. 1995 Evidence of coexisting changes in 11β-hydroxysteroid dehydrogenase and 5β-reductase activity in patients with untreated essential hypertension. Hypertension. 25:67-70.
23. Stewart PM, Shackleton CHL, Beastall GH, Edwards CRW. 1990 5alpna-reductase activity in polycysric ovarian syndrome. Lancet. 335:431-433.